These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10755070)

  • 1. Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex.
    Eastwood SL; Cairns NJ; Harrison PJ
    Br J Psychiatry; 2000 Mar; 176():236-42. PubMed ID: 10755070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
    Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
    Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia.
    Eastwood SL; Burnet PW; Harrison PJ
    Neuroscience; 1995 May; 66(2):309-19. PubMed ID: 7477874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study.
    Eastwood SL; Burnet PW; McDonald B; Clinton J; Harrison PJ
    Neuroscience; 1994 Apr; 59(4):881-92. PubMed ID: 8058126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia.
    Glantz LA; Austin MC; Lewis DA
    Biol Psychiatry; 2000 Sep; 48(5):389-97. PubMed ID: 10978722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular basis of reduced cortical reelin expression in schizophrenia.
    Eastwood SL; Harrison PJ
    Am J Psychiatry; 2006 Mar; 163(3):540-2. PubMed ID: 16513881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
    Eastwood SL; Harrison PJ
    Schizophr Res; 2005 Mar; 73(2-3):159-72. PubMed ID: 15653259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients.
    Habl G; Schmitt A; Zink M; von Wilmsdorff M; Yeganeh-Doost P; Jatzko A; Schneider-Axmann T; Bauer M; Falkai P
    Neuropsychobiology; 2012; 66(1):57-62. PubMed ID: 22797278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
    Glantz LA; Lewis DA
    Arch Gen Psychiatry; 1997 Oct; 54(10):943-52. PubMed ID: 9337775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
    Glantz LA; Lewis DA
    Arch Gen Psychiatry; 1997 Jul; 54(7):660-9. PubMed ID: 9236550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography.
    Eastwood SL; Harrison PJ
    Neuroscience; 1995 Nov; 69(2):339-43. PubMed ID: 8552231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
    Karson CN; Mrak RE; Schluterman KO; Sturner WQ; Sheng JG; Griffin WS
    Mol Psychiatry; 1999 Jan; 4(1):39-45. PubMed ID: 10089007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections.
    Eastwood SL; Harrison PJ
    Neuroscience; 1999; 93(1):99-106. PubMed ID: 10430474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders.
    Xing G; Zhang L; Russell S; Post R
    Schizophr Res; 2006 May; 84(1):36-56. PubMed ID: 16631355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
    Osimo EF; Beck K; Reis Marques T; Howes OD
    Mol Psychiatry; 2019 Apr; 24(4):549-561. PubMed ID: 29511299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.
    Eastwood SL; Harrison PJ
    Brain Res Bull; 2001 Jul; 55(5):569-78. PubMed ID: 11576753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia.
    Eastwood SL; Harrison PJ
    Neuroscience; 1998 Sep; 86(2):437-48. PubMed ID: 9881859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in the hippocampal formation and cerebral cortex.
    Harrison PJ; Burnet PW; Falkai P; Bogerts B; Eastwood SL
    Schizophr Res; 1997 Aug; 26(2-3):93-102. PubMed ID: 9323338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia.
    Harrison PJ; Eastwood SL
    Lancet; 1998 Nov; 352(9141):1669-73. PubMed ID: 9853440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebellar synaptic protein expression in schizophrenia.
    Eastwood SL; Cotter D; Harrison PJ
    Neuroscience; 2001; 105(1):219-29. PubMed ID: 11483314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.